09. COPD, Emphysema, Chronic Bronchitis, Alpha-1 Antitrypsin Deficiency -> Adult -> Health Services Research/Quality Improvement/Implementation Science

Evaluating Current Discharge Practices After Acute COPD Exacerbation for Areas of Improvement to Ensure Delivery of Quality Care

Poster Board Number
616
Presenter:
  • M. MacDonald
Session Number
D21
Session Title:
D21 - HEALTH CARE QUALITY AND UTILIZATION IN PATIENTS WITH COPD
Session Type:
Poster Discussion Session
Authors
  • M. MacDonald
  • K. Goss

Previous Eposter
Reduced Pneumococcal Antibody Function Is Associated with Exacerbations of COPD in SPIROMICS

Next Eposters
Burden of Respiratory Symptoms in Older Adults with Underdiagnosed and Misdiagnosed of COPD: Results from the Canadian Longitudinal Study of Aging
FOOTPRINTS® Study Methodology and Baseline Characteristics: A 3-Year Longitudinal Study to Phenotype Patients with COPD
A Predictive Model for COPD Exacerbations Using ProAir Digihaler: A 12-Week, Open‑Label Study
Biomarkers to Predict Forced Expiratory Volume in 1 Second (FEV1) Decline in Healthy Smokers and Early-Onset Chronic Obstructive Pulmonary Disease (COPD)
GDF-15, Pentraxin-3 and TIMP-1 Plasma Biomarkers Improve Risk Assessment for Mortality in Ambulatory Veterans with COPD
Cardiovascular Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Chronic Obstructive Pulmonary Disease (COPD): A 24-Hour Holter Monitoring Sub-Study of the ETHOS Trial
Chronic Obstructive Pulmonary Disease Plus (COPD+)® as a Friendly App for Patients with Chronic Obstructive Pulmonary Disease
Insights from Mid-Expiratory Flow Rate (FEF25-75%) in Ever-Smokers with Preserved Lung Function in the Subpopulations and Intermediate Markers in COPD Study (SPIROMICS) Cohort
Club Cell Protein-16 (CC16) Is Reduced in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Relationship of Dorsal Hyperkyphosis with Quality of Life in Patients with COPD in Northeastern Colombia